在焦点发作形式的MOGAD令人困惑的开始
Małgorzata Jączak-Goździak1, Barbara Steinborn1
1Department of Developmental Neurology, Poznan University of Medical Sciences, 61-701 Poznań, Poland.
Neurology international
|March 26, 2025
概括
髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 可以在典型的脱髓化症状之前出现初始的焦点发作. 早期诊断需要在评估中考虑MOGAD.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 脱线性疾病 脱线性疾病
背景情况:
- 髓寡细胞糖蛋白抗体相关疾病 (MOGAD) 是一种脱髓化疾病,与多发性硬化症和神经omyelitis optica 谱系疾病不同.
- MOGAD通常影响儿童群体,并呈现出各种临床表现,包括急性传播性脑膜炎 (ADEM),视神经炎 (ON) 和横向脑膜炎 (TM).
研究的目的:
- 要突出一个罕见的MOGAD病例,其中焦点发作是最初的症状.
- 强调在对的差异诊断中考虑MOGAD的重要性,特别是在排除其他原因时.
- 强调需要扩展诊断方法,包括针对脱髓化疾病的抗体检测.
主要方法:
- 一个17岁的患者的病例报告,最初的焦点发作.
- 诊断工作包括MRI,神经抗体的排除,以及以后的MOGAD特异性抗体测试.
- 治疗包括类固醇,免疫球蛋白,等离子体和抗药物.
主要成果:
- 患者最初的表现是上腺瘤手术后的焦点发作,最初怀疑是副瘤综合征.
- 随后的复发与典型的MOGAD特征 (ADEM,MDEM,复发的ON) 证实了诊断.
- 患者的随着治疗而消失,在复发期间可以管理MOGAD.
结论:
- MOGAD可以具有多相和临床多样化的过程,作为罕见的初始表现.
- 的诊断评估应包括检测脱髓化疾病,特别是抗MOG和抗AQP4抗体.
- 这一案例强调了扩大诊断的必要性,以包括神经炎症和非髓化疾病.
更多相关视频
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.5K
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.1K
相关概念视频
01:13Seizures: Classification
293
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
293
01:20Antiepileptic Drugs: Potassium Channel Activators
138
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
138
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
300
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
300
01:14Antiepileptic Drugs: Glutamate Antagonists
264
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
264
01:19Cranial and Spinal Meninges
1.1K
The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
1.1K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
206
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
206